| 000 | 01595 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515015734.0 | ||
| 264 | 0 | _c20060428 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6603028 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeinlich, G | |
| 245 | 0 | 0 |
_aMetallothionein - overexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cMar 2006 |
||
| 300 |
_a835-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xgenetics |
| 650 | 0 | 4 |
_aMetallothionein _xbiosynthesis |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aSkin Neoplasms _xgenetics |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aEisendle, K | |
| 700 | 1 | _aHassler, E | |
| 700 | 1 | _aBaltaci, M | |
| 700 | 1 | _aFritsch, P O | |
| 700 | 1 | _aZelger, B | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 94 _gno. 6 _gp. 835-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6603028 _zAvailable from publisher's website |
| 999 |
_c16119053 _d16119053 |
||